Applications focused on LC/SQ from Waters - page 5

Supporting Pharmaceutical Synthetic Process R&D Using LC-MS

Applications

| 2024 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

Leveraging Mobile Phase pH to Optimize Separations for Improved Prep Performance Using Columns Packed With Waters™ Hybrid Particles

Applications

| 2024 | Waters

Consumables, LC columns, LC/MS, LC/SQ

Instrumentation

Consumables, LC columns, LC/MS, LC/SQ

Manufacturer

Waters

Industries

Method Development of Orlistat Forced Degradation Sample using MaxPeak™ Premier Columns and QDa™ Mass Detection

Applications

| 2024 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

ACQUITY QDa II Mass Detector brochure

Brochures and specifications

| 2024 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Other

Simplified Routine QC Monitoring of Glycans Using ACQUITY™ QDa™ II Mass Detector

Applications

| 2024 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

Lipid Nanoparticle Impurity Monitoring Using Single Quadrupole Mass Detection for Regulated Environments

Posters

| 2023 | Waters (ASMS)

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

DIRECT MASS DETECTION AS A RAPID, AT-POINT-OF- SAMPLING, SCREENING TOOL

Posters

| 2023 | Waters

LC/MS, DART, LC/SQ

Instrumentation

LC/MS, DART, LC/SQ

Manufacturer

Waters

Industries

Updating the RADIAN™ ASAP™ Seized Drug Reference Library

Technical notes

| 2023 | Waters

LC/MS, DART, LC/SQ

Instrumentation

LC/MS, DART, LC/SQ

Manufacturer

Waters

Industries

Forensics

Efficient Method Development for the Analysis of Naphazoline Hydrochloride, Pheniramine Maleate, and Associated Related Substances Using a Systematic Screening Protocol

Applications

| 2023 | Waters

HPLC, LC/MS, LC/SQ

Instrumentation

HPLC, LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

Using a Systematic Screening Protocol and MaxPeak™ HPS Technology to Develop a UHPLC Method for the Analysis of Deferoxamine and its Forced Degradation Products

Applications

| 2023 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma